Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-036024
Filing Date
2022-11-16
Accepted
2022-11-16 17:30:29
Documents
1
Period of Report
2022-11-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5297
  Complete submission text file 0000899243-22-036024.txt   6916
Mailing Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210
Business Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210 (877) 442-5362
Ginkgo Bioworks Holdings, Inc. (Issuer) CIK: 0001830214 (see all company filings)

EIN.: 872652913 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 667 MADISON AVENUE C/O CORVEX MANAGEMENT LP NEW YORK NY 10065
Business Address
Kelly Jason R (Reporting) CIK: 0001845677 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40097 | Film No.: 221396221